Panakeia to attend upcoming scientific and business conferences
- Stella Lempidaki
- 16 minutes ago
- 2 min read
Cambridge, UK, 3 November 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm that various team members will be attending and presenting at a number of conferences as detailed below.
Panakeia’s AI-driven software provides comprehensive multi-omic information (DNA, RNA, protein, metabolite changes) directly from routinely used images of tissues and cells in minutes instead of days or weeks, without the need for wet-lab tests. The software enables same-day treatment decision-making in the clinic and fast-tracks drug development for biopharma.
Barclays Entrepreneur Awards, November 6, London, UK
ESMO AI & Digital Oncology, November 12–14, Berlin, Germany
London Life Sciences Week, November 16–21, London, UK
Investival Showcase, November 17, London, UK
European Lifestars Awards, November 17, London, UK
Slush, November 19–20, Helsinki, Finland
RCPath Meeting, November 24, London, UK
If you would like to meet with the Panakeia team in any of the above conferences, please get in touch via the contact form on our website.
About Panakeia
Panakeia is a pioneer in AI-enabled molecular profiling. The Company’s AI-driven software provides comprehensive multi-omic information (DNA, RNA, protein, metabolite changes) directly from routinely used images of tissues and cells in minutes instead of days or weeks. The software enables same-day treatment decision-making in the clinic and fast-tracks drug development for biopharma without the need for time and resource intensive laboratory tests.
Panakeia’s PANProfiler platform is available as a research use tool for patient screening in clinical trials. The Company’s two clinical products for breast and colon cancers are built using the PANProfiler platform. These products are approved and clinically deployed in the UK with several more products in the pipeline.
Headquartered in Cambridge, UK, Panakeia is focused on improving the speed and accuracy of pathology examinations for all patients.
To learn more about Panakeia’s platform visit: https://www.panakeia.ai/
For more information please contact:
Stella Lempidaki, PhD
Head of Communications
